A Plus Biotechnology Co., Ltd.

Research A Plus Biotechnology Co., Ltd. (6918.TW) on Bullrun: market cap TWD 2.56B, P/E 13.9, dividend yield 6.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 2.56B; P/E is 13.9; dividend yield is 6.7%.

Peer valuation comparison

Latest P/E is 13.91x versus a Healthcare sector median of 21.8x (36.2% below).

Latest dividend yield is 6.68% versus a Healthcare sector median of 2.4% (178.3% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 2.56B13.96.7%5

Dividend history

Latest trailing dividend snapshot: annual dividend/share 5 TWD, yield 6.7%.

About A Plus Biotechnology Co., Ltd.

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of medical devices in Taiwan, China, and internationally. The company provides bone graft materials and other medical devices, as well as technical support services. It also offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, and biologics.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is A Plus Biotechnology Co., Ltd.'s market cap?

A Plus Biotechnology Co., Ltd.'s market capitalization is TWD 2.56B.

What is A Plus Biotechnology Co., Ltd.'s P/E ratio?

A Plus Biotechnology Co., Ltd.'s price-to-earnings (P/E) ratio is 13.9.

Does A Plus Biotechnology Co., Ltd. pay a dividend?

A Plus Biotechnology Co., Ltd. has a dividend yield of 6.7%.

What does A Plus Biotechnology Co., Ltd. do?

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of medical devices in Taiwan, China, and internationally. The company provides bone graft materials and other medical devices, as well as technical support services. It also offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, and biologics.